Researchers Developing Blood Test To Improve Diagnosis Of Sickle Cell Disease In Babies
9/07/2011
A new blood test is being developed by researchers in Cambridge and Oxford, which, for the first time, could help identify babies at risk of a severe form of sickle cell disease, allowing immediate and more intensive treatment to be given, thanks to a grant from children's charity Action Medical Research...
Study Of Cell Communication Could Lead To New Cancer Drugs And More
9/07/2011
Cell communication is essential for the development of any organism. Scientists know that cells have the power to "talk" to one another, sending signals through their membranes in order to "discuss" what kind of cell they will ultimately become - whether a neuron or a hair, bone, or muscle. And because cells continuously multiply, it's easy to imagine a cacophony of communication...
News From The Annals Of Internal Medicine: Sept. 6, 2011
9/07/2011
Making Multiple Lifestyle Improvements Can Significantly Reduce Diabetes Risk It is well-documented that lifestyle factors such as diet, weight, physical activity, smoking habits, and alcohol consumption affect a person's risk for diabetes. Studies have shown that individual lifestyle improvements, such as quitting smoking, can delay or prevent the onset of diabetes...
Blood Supply Threatened By Tickborne Parasite Babesia, Screening Of Blood Donors Required, Says CDC
9/06/2011
US blood supplies are becoming increasingly infected with Babesia, a tickborne parasite of red blood cells. The infection is transmitted through blood transfusions...
NIH Scientists Repurpose FDA-Approved Drug To Target Specific Defect Causing WHIM Syndrome
9/06/2011
A new study reports that a drug already approved by the Food and Drug Administration for use in patients undergoing a bone marrow transplant may also have promise for treating people who have a rare immune deficiency known as WHIM syndrome...
Gene Mutation Shown To Cause Leukaemia And Lymphoedema
9/06/2011
Researchers have discovered a gene that when mutated can cause lymphoedema (swollen limbs due to a failure of the lymph system), immune abnormalities, deafness and leukaemia. The identification of the gene responsible for causing this rare combination of medical conditions, known as Emberger syndrome, could allow earlier identification and treatment of those at risk...
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that the European Commission has approved Tarceva® (erlotinib) for use in patients with a genetically distinct type of non-small cell lung cancer (NSCLC) in Europe...
New Drug Approved For Treatment Of Non Small Cell Lung Cancer In Specific Patient Population
9/06/2011
Lung Cancer Alliance (LCA) applauds the Food and Drug Administration (FDA) approval of Xalkori (crizotinib) with non-small cell lung cancer (NSCLC) who are ALK positive. The drug was approved based on data from two clinical trials, both of which showed a significant increase in overall survival...
New Strategy For Treating Cancer
9/06/2011
Using a strategy based on treating cancer cells that carry a specific genetic signature hyper-expression of the protein Myc with therapy that affects the stability of the cell's DNA, more effective results can be achieved. This was discovered by Andreas Höglund in his dissertation to be publicly defended at Umeå University on September 9...
Walnuts Reduce Breast Cancer Risk By Half In Animal Studies
9/06/2011
Mice fed a diet that included daily walnuts had half the risk of developing breast cancer compared to those on a typical diet, researchers from Marshal University School of Medicine reported in the journal Nutrition and Cancer. Elaine Hardman, Ph.D...